Literature DB >> 24676898

A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA.

Susan Clemens1, Nelufa Begum, Catherine Harper, Jennifer A Whitty, Paul A Scuffham.   

Abstract

PURPOSE: To provide population norms for the EQ-5D-3L by age and gender based on a representative adult sample in Queensland, Australia; to assess differences in health-related quality of life by applying the Australian, UK and USA value sets to these data; and to assess differences in utility scores for key preventive health indicators.
METHODS: A cross-sectional computer-assisted telephone interview survey (March-June 2011) with 5,555 adults. Respondents rated their impairment (none, moderate, severe problems) across five domains (mobility, self-care, usual activities, pain and discomfort, anxiety or depression) using the validated EQ-5D-3L health-related quality of life instrument. Utility score indexes were derived using the Australian, UK and USA value sets.
RESULTS: Forty per cent of adults reported pain and discomfort while 3% indicated problems with self-care. Approximately one in six had limitations with mobility, usual activities or anxiety or depression. The three value sets performed similarly in discriminating differences based on most characteristics, and clinically meaningful differences were seen for age, body weight, physical activity and daily smoking. There were no differences in utility scores for gender.
CONCLUSIONS: This is the first study to report general population findings for the Australian EQ-5D-3L value set. Overall, the Australian value set performed comparably with other value sets commonly used in the Australian population; however, differences were observed. Results will enable further refinement to health and economic studies in an Australian-specific context.

Entities:  

Mesh:

Year:  2014        PMID: 24676898     DOI: 10.1007/s11136-014-0676-x

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  13 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments.

Authors:  G Hawthorne; J Richardson; N A Day
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

Review 3.  Multi-attribute health status classification systems. Health Utilities Index.

Authors:  D Feeny; W Furlong; M Boyle; G W Torrance
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

Review 4.  Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.

Authors:  Stephen J Walters; John E Brazier
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

5.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

6.  A national catalog of preference-based scores for chronic conditions in the United States.

Authors:  Patrick W Sullivan; William F Lawrence; Vahram Ghushchyan
Journal:  Med Care       Date:  2005-07       Impact factor: 2.983

Review 7.  International comparisons in valuing EQ-5D health states: a review and analysis.

Authors:  Richard Norman; Paula Cronin; Rosalie Viney; Madeleine King; Deborah Street; Julie Ratcliffe
Journal:  Value Health       Date:  2009-08-20       Impact factor: 5.725

8.  Time trade-off derived EQ-5D weights for Australia.

Authors:  Rosalie Viney; Richard Norman; Madeleine T King; Paula Cronin; Deborah J Street; Stephanie Knox; Julie Ratcliffe
Journal:  Value Health       Date:  2011-08-04       Impact factor: 5.725

9.  Modeling valuations for EuroQol health states.

Authors:  P Dolan
Journal:  Med Care       Date:  1997-11       Impact factor: 2.983

10.  Danish EQ-5D population norms.

Authors:  Jan Sørensen; Michael Davidsen; Claire Gudex; Kjeld Møller Pedersen; Henrik Brønnum-Hansen
Journal:  Scand J Public Health       Date:  2009-06-17       Impact factor: 3.021

View more
  37 in total

1.  Population norms for the EQ-5D index scores using Singapore preference weights.

Authors:  Edimansyah Abdin; Mythily Subramaniam; Janhavi Ajit Vaingankar; Nan Luo; Siow Ann Chong
Journal:  Qual Life Res       Date:  2014-11-14       Impact factor: 4.147

2.  SF-6D population norms for the Hong Kong Chinese general population.

Authors:  Carlos K H Wong; Brendan Mulhern; Garvin H L Cheng; Cindy L K Lam
Journal:  Qual Life Res       Date:  2018-05-24       Impact factor: 4.147

3.  Jumping into the deep-end: results from a pilot impact evaluation of a community-based aquatic exercise program.

Authors:  Anna L Barker; Jason Talevski; Renata T Morello; Genevieve A Nolan; Renee D De Silva; Andrew M Briggs
Journal:  Clin Rheumatol       Date:  2015-10-29       Impact factor: 2.980

4.  Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People's Quality of Life Brief Questionnaire (OPQoL-Brief) Scores.

Authors:  Billingsley Kaambwa; Julie Ratcliffe
Journal:  Patient       Date:  2018-02       Impact factor: 3.883

5.  Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.

Authors:  Laura Catherine Edney; Hossein Haji Ali Afzali; Terence Chai Cheng; Jonathan Karnon
Journal:  Pharmacoeconomics       Date:  2018-02       Impact factor: 4.981

6.  Establishing benchmark EQ-5D-3L population health state utilities and identifying their correlates in Gansu Province, China.

Authors:  Lei Si; Lei Shi; Mingsheng Chen; Andrew J Palmer
Journal:  Qual Life Res       Date:  2017-06-07       Impact factor: 4.147

7.  Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China.

Authors:  Liu Liu; Shunping Li; Yue Zhao; Jianglin Zhang; Gang Chen
Journal:  Qual Life Res       Date:  2018-02-28       Impact factor: 4.147

8.  Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA.

Authors:  Deshan F Sebaratnam; Joyce Okawa; Aimee Payne; Dédée F Murrell; Victoria P Werth
Journal:  Qual Life Res       Date:  2015-03-21       Impact factor: 4.147

9.  Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia.

Authors:  Masnoon Saiyed; Joshua Byrnes; Tushar Srivastava; Paul Scuffham; Martin Downes
Journal:  Clin Drug Investig       Date:  2020-11-02       Impact factor: 2.859

10.  Cost-Effectiveness Analysis of a Mobile Ear Screening and Surveillance Service versus an Outreach Screening, Surveillance and Surgical Service for Indigenous Children in Australia.

Authors:  Kim-Huong Nguyen; Anthony C Smith; Nigel R Armfield; Mark Bensink; Paul A Scuffham
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.